Point72 Asia (Singapore)’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$56	Buy	+50	New	+$56	﹤0.01%	838
2025 Q1	–	Sell	-33,094	Closed	-$54.6K	–	979
2024 Q4	$54.6K	Buy	+33,094	New	+$54.6K	0.01%	492
2024 Q1	–	Sell	-14,805	Closed	-$55.4K	–	1118
2023 Q4	$55.4K	Buy	+14,805	New	+$55.4K	0.01%	291